We are live on
!
Find out more
InMed Pharmaceuticals
7 hedge funds and large institutions have $28.5K invested in InMed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
115% more capital invested
Capital invested by funds: $13.3K → $28.5K (+$15.2K)
40% more funds holding
Funds holding: 5 → 7 (+2)
0.17% more ownership
Funds ownership: 0.53% → 0.7% (+0.17%)
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.59K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.11K |
| 3 |
Bessemer Group
Woodbridge,
New Jersey
|
+$3 |
Top Sellers
No sellers this quarter